Tag: Antisense Therapeutics
Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study
Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology study
Antisense Therapeutics (ANP) commences the dosing stage of a nine-month chronic monkey toxicology study of...
Antisense Therapeutics: Receives first approval for phase two DMD clinical trial
Antisense Therapeutics Receives first approval for phase two DMD clinical trial
Antisense Therapeutics (ANP) receives approval to conduct its phase two trial in non-ambulant...
Antisense Therapeutics: Shares rise on long COVID-19 study
Antisense Therapeutics Shares rise on long COVID-19 study
Antisense Therapeutics (ANP) announces the outcomes of its collaboration to study the neurological aspects of long...